Category: Abiomed Inc.Syndicate content

Abiomed reups license on Opsens fiber-optic pressure sensors

April 15, 2014 by Brad Perriello

Abiomed says it's renewing a licensing deal with Opsens for fiber-optic pressure sensor technology to integrate into its Impella line of heart pumps.

Abiomed reups license on Opsens fiber-optic pressure sensors

Abiomed (NSDQ:ABMD) said it renewed a licensing deal with Opsens (TSX:OPS.V) to integrate that company's fiber-optic pressure sensor technology into Abiomed's Impella line of heart pumps.

Abiomed escapes shareholder lawsuit

April 11, 2014 by Brad Perriello

A federal judge dismisses a shareholder lawsuit filed over Abiomed's alleged off-label marketing of its Impella heart pump.

Abiomed escapes shareholder lawsuit

Abiomed (NSDQ:ABMD) escaped a consolidated lawsuit filed over its alleged off-label marketing for the Impella 2.5 heart pump yesterday, when a federal judge dismissed the case.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Abiomed wins CE Mark for Impella RP heart pump

April 8, 2014 by Brad Perriello

Abiomed says it won CE Mark approval in the European Union for its Impella RP right-side heart pump.

YYmeta

Abiomed (NSDQ:ABMD) said it won CE Mark approval in the European Union for its Impella RP heart pump, designed to assist the heart's right ventricle in heart failure patients.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Abiomed jumps on Medicare reimbursement news

March 21, 2014 by Brad Perriello

The Centers for Medicare & Medicaid say they plan to keep the same reimbursement rate for treatment with Abiomed's Impella heart pump, sending ABMD shares up on Wall Street.

Abiomed jumps on Medicare reimbursement news

Abiomed (NSDQ:ABMD) said today that the Centers for Medicare & Medicaid Services plan to maintain the reimbursement rate for treatment with its Impella heart pump when new rates go into effect this fall.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Abiomed hits enrollment goal in Recover Right trial

March 20, 2014 by Brad Perriello

Abiomed says it hit the 30-patient mark in the Recover Right study of its Impella RP heart pump.

Abiomed hits enrollment goal in Recover Right trial

Abiomed (NSDQ:ABMD) said it plans to ask the FDA to allow more patients to enroll in the Recover Right trial of its Impella RP right-side heart pump, now that it's met the 30-patient goal for the study.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

MedTech Veterans Program expands, names new president

February 12, 2014 by Chris Walker

The Medical Technology Veterans Program expands to include life sciences, adds BioCollaborative and names Mike Grice its new president.

MedTech Veterans Program expands, names new president

The Medical Technology Veterans Program is broadening its scope, adding biotechnology, life sciences and diagnostic industries. The expansion comes with a new name for the group, now called the MedTech & BioTech Veterans Program.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp